leisure time -WSS

leisure time

author：knowledge 2025-09-14 14:44:00 - browse：7283

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： First U.S. drug developed to treat liver disease MASH is approved

explore

WSS

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Grad students accuse University of California of wage theft

First U.S. drug developed to treat liver disease MASH is approved

Medicare to pay more for cardiac rehab in hospital outpatient clinics

WuXi out of biotech trade group, U.S. and China relations to blame

People with substance use disorder deserve online privacy

knowledge

leisure time

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medicare to pay more for cardiac rehab in hospital outpatient clinics

How one medical school became remarkably diverse

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Medicare proposal to cover medical devices draws a mixed reaction

Chamber of Commerce, DOJ clash in court over drug prices

Virginia high school admissions case could be legal follow

FDA weighs limits of animal data in assessing artificial wombs

Jerome Adams on the need for new antivirals for Covid

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

entertainment

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Chamber of Commerce, DOJ clash in court over drug prices

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Chamber of Commerce, DOJ clash in court over drug prices

Change Healthcare outage fallout shows need for new oversight

Why the quest to eradicate polio has stumbled

focus

explore

focus

focus